Edwards Lifesciences Dividends and Buybacks
Dividend criteria checks 0/6
Edwards Lifesciences does not have a record of paying a dividend.
Key information
n/a
Dividend yield
2.4%
Buyback Yield
| Total Shareholder Yield | 2.4% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Why Edwards Lifesciences Corporation (NYSE:EW) Could Be Worth Watching
Sep 20
Here's What's Concerning About Edwards Lifesciences' (NYSE:EW) Returns On Capital
Sep 05Edwards Lifesciences: Gradually Winning My Investment Heart
Aug 18Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Jul 16
Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Apr 15Edwards Lifesciences (NYSE:EW) Will Want To Turn Around Its Return Trends
Apr 01Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead
Mar 23A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Mar 18At US$71.45, Is It Time To Put Edwards Lifesciences Corporation (NYSE:EW) On Your Watch List?
Feb 26Edward Lifesciences: A Closer Look At Growth And Valuation
Jan 05Edwards Lifesciences Corporation's (NYSE:EW) Price Is Out Of Tune With Earnings
Dec 23Is Edwards Lifesciences (NYSE:EW) A Risky Investment?
Dec 09At US$71.27, Is Edwards Lifesciences Corporation (NYSE:EW) Worth Looking At Closely?
Nov 26Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Nov 11Edwards Lifesciences Q3: Divesting Critical Care And Focusing On Structural Hearts
Oct 25Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
Jul 26Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
Jun 22Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
May 09Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if EW's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EW's dividend payments have been increasing.
Dividend Yield vs Market
| Edwards Lifesciences Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (EW) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.4% |
| Industry Average (Medical Equipment) | 1.7% |
| Analyst forecast (EW) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate EW's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate EW's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate EW's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as EW has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/05 07:05 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Edwards Lifesciences Corporation is covered by 70 analysts. 32 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Francis Mainwaring | Atlantic Equities LLP |
| David Rescott | Baird |
| Ishan Majumdar | Baptista Research |